Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
The individual ingredients have varying levels of scientific support, but the complete product has never been tested
10.1007/BF02346248 31
Type 2 Diabetes & Glycaemic Control SURPASS clinical program data shows exceptional HbA1c reductions (up to 2.3%) with low hypoglycaemia risk
FDA Commissioner Makary had also published a JAMA editorial accusing Hims of a breach of FDA regulation with its 2025 Super Bowl advertisement, which promoted weight-loss drugs without adequately disclosing side effects
You might not even think about it
Enhanced Insulin Sensitivity: These treatments boost insulin secretion in response to meals, which is particularly advantageous for women facing insulin resistance during hormonal fluctuations
US$ 29.71
US$ 22.86
US$ 27.80
US$ 27.58
US$ 25.36
US$ 23.20
